로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
GMP IL-15 NEW |Omicron specific antibody Hot |Claudin 18.2 |CD3 |GPCRs
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: 홈 > Insights
뉴스
인사이트
전시회
프로모션
Inspiring Target: Integrin α4/β7 (LPAM-1)
To accelerate the research and development of integrin-targeting drugs, ACROBiosystems has a catalog of all 24 known integrin heterodimers, including integrin α4/β7, expressed through our HEK293 platform and verified by SEC-MALS.
2023/03/15     Read: 565
CAR-NK Cell Therapies: Not Completely CRS-proof?
With the increase in CAR-NK and the research into other CAR cell therapies, understanding the cytokine signaling pathway is a must: not only for learning the biological effects but also in the clinical space for diagnostics and treatment strategies. Identifying immune-cell specific or a set of cytok
2023/03/07     Read: 638
CAR Expression Detection throughout Cell Therapy Development, from Start to Finish
Following the success of cell therapy in treating leukemia and other hematological disorders, next-generation CAR cell therapy research has emphasized the need for improved manufacturing and quality control standards. With the release of new FDA guidelines on CAR cell manufacturing, one key aspect i
2023/02/22     Read: 1898
Custom GMP-grade Protein Services for Cell Therapeutic Manufacturing
ACROBiosystems launches custom GMP-grade protein development services for cell therapeutic manufacturing.We strive to be the best key materials supplier with products that are structurally designed to accompany you throughout the studies needed in development,clinical research, and beyond.
2023/02/14     Read: 1927
Facilitating Antibody Development with Recombinant Antibody Services
ACROBiosystems provide recombinant antibody expression and production services based on HEK293 and CHO cells.Starting from the sequence information of antibodies,we deliver recombinant antibody with high purity and low endotoxin level.
2023/02/14     Read: 1773
Coming Soon, The RSV Vaccines
Respiratory syncytial virus (RSV) is a significant contributor to infant mortality with limited prevention and treatment options. The fusion glycoprotein of RSV is thought as an ideal target for vaccine R&D, which exists in pre- and post-fusion forms. Due to their different performance in inducing n
2023/02/03     Read: 1983
An interview with CEO of ACROBiosystems, Mike Chen — Transforming Customer Journey
ACROBiosystems provides life sciences tools, reagents, and instruments,and aims to become the'cornerstone'of the pharma and biotech industry
2023/01/06     Read: 3061
Pre-formed Fibrils: Another Perspective in Modelling of Neurodegenerative Diseases
PFFs is a novel approach to modeling neurodegenerative diseases. Aneuro provides Tau-441 PFFs、alpha-synuclein PFFs、Amyloid beta PFFs、TDP-43 PFFs and SOD-1 PFFs.
2022/12/27     Read: 1738
Evaluating Inhaled Aerosol Vaccines: No-needle COVID-19 Protection?
The COVID-19 epidemic has now entered its third year with its effects still being felt across the world. In many countries, there have been an alarming trend of waning vaccine efficacy paired with the emergence of variants with stronger immune escape and transmission ability. This consistent challen
2022/12/26     Read: 4080
Tackling Solid Tumors:The Next Hurdle for Cell Therapies
ACROBiosystems has developed a series of solid tumor-related targets. These products can be used for immune screening, CAR detection and PK study .
2022/12/14     Read: 2299
더.

This web search service is supported by Google Inc.

totop
Call us
우리에게 전화하세요
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
Email
이메일
order.kr@acrobiosystems.com
Fax
팩시
+1 888-377-6111
Address
주소
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

대글

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap